Data / Form D filings / Mill Creek Life Sciences, LLC
Mill Creek Life Sciences, LLC: Form D filings
Mill Creek Life Sciences, LLC, a biotechnology company in Rochester, MN, filed 4 Form D notices with the SEC between 2011 and 2019. The latest, on February 7, 2019, reports an offering of $5 million with nothing sold yet.
Find out what Mill Creek Life Sciences, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 212 1ST AVENUE SW, STE 209, Rochester, MN, 55902
- Phone
- (507) 287-6257
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Iowa
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1529932
The full lists. Form D filings in Minnesota: 692 rows, $34.60, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 7, 2019 | New notice | $5,000,000 | $0 | $5,000,000 | 0 | Yet to occur | sec.gov |
| Oct 10, 2013 | New notice | $4,275,000 | $0 | $4,275,000 | 0 | Yet to occur | sec.gov |
| Sep 14, 2012 | Amendment | $1,500,000 | $625,000 | $875,000 | 8 | Sep 6, 2011 | sec.gov |
| Sep 15, 2011 | New notice | $1,500,000 | $100,000 | $1,400,000 | 1 | Sep 6, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Douglas L Punke | Director | |
| Franklyn G Prendergast | Director | |
| Allan B Dietz | Director | |
| Janet L Einspahr | Director | |
| Steven L Dietz | Executive Officer, Director | |
| William L Mirsch | Executive Officer, Director |
Other biotechnology companies in Minnesota that filed recently
- Medical 21, Inc. $550,000 · Oct 23, 2026
- InSitu Biologics, Inc. $1.3 million · Oct 14, 2026
- Evia Bio, Inc. $5.5 million · Sep 28, 2026
- EyeMacular Regeneration, Inc. $2.9 million · Sep 25, 2026
- ProEncia Biotechnology Inc. $1.5 million · Aug 26, 2026
Every Form D from the week of Feb 4, 2019 · All recent filings in Minnesota · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Mill Creek Life Sciences, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.